Kimberly-Clark Corporation KMB

NASDAQ · Consumer Defensive · Household & Personal Products

$106.38

Close on Fri, 20 Nov 2026 · market value $35.4B

What the price is betting on

In line with its record

At $106, the price assumes revenue shrinks about 3.5% a year for three years, from $16.6B to about $15.3B by FY2028. That is less than what analysts expect and about the same as the company's own last three years.

The price assumes−3.5%
Analysts expect18%
Last 3 years−7.3%

Revenue growth a year. The price figure comes from a reverse DCF at a 6.6% discount rate.

Track it and Parra checks each report against the path, and tells you when revenue falls behind it.

Own more than KMB? Check up to 5 of your stocks at once, free, no account.

0$10B$20B$30B$40B$16.6B'22'23'24'25Sep '26'26'27'28What the price needsReportedAnalysts

Both sides

Three stories, three values

Bear

$224

Base

$142

Bull

$431

Today $106

  • Bear $224. The business grows 11% a year on average for only 1 year, then slows down.
  • Base $142. The business grows 18% a year on average over the 3 years analysts forecast, shaped like their forecast, then slows over 10 years, starting from -12%.
  • Bull $431. The business grows 25% a year on average for 5 years, longer than analysts forecast, then slows down.

Stories set by rules from the company’s record.

Checkpoints

The revenue the price needs

  1. YearNeedsAnalysts expect
  2. FY2026$16.4B$18.4B, on the path
  3. FY2027$15.8B$32.9B, on the path
  4. FY2028$15.3B$30.5B, on the path

Each year's revenue at −3.5% growth from $16.6B in the 12 months to September 2026.

At a glance

Consumer Defensive · Household & Personal Products · listed on NASDAQ

Revenue, FY2025
$16.4B
Growth, 3 years a year
−7.3%
Cash margin
10%
Net debt
$6.6B
Shares, 3-year change
−1.5%
Dividend yield
4.7%

What other consumer defensive prices are betting on

Figures from company filings and end-of-day market data, as of the close on Fri, 20 Nov 2026; updated every trading day. This page shows what today's price assumes, not whether to buy or sell. Not investment advice.